Entest Biomedical Inc
Entest Group, Inc. does not have significant operations. It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. The company was formerly known as Entest Biomedical, Inc. and changed its name to Entest Group, Inc. in February 2018. Entest Group, Inc. was founded in 2008 and i… Read more
Market Cap & Net Worth: Entest Biomedical Inc (ETNI)
Entest Biomedical Inc (PINK:ETNI) has a market capitalization of $147.51K ($147.51K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45020 globally and #14197 in its home market, demonstrating a 1400.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Entest Biomedical Inc's stock price $0.00 by its total outstanding shares 49171083 (49.17 Million).
Entest Biomedical Inc Market Cap History: 2015 to 2025
Entest Biomedical Inc's market capitalization history from 2015 to 2025. Data shows change from $737.57K to $147.51K (-16.49% CAGR).
Entest Biomedical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Entest Biomedical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ETNI by Market Capitalization
Companies near Entest Biomedical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Entest Biomedical Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Entest Biomedical Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Entest Biomedical Inc's market cap moved from $737.57K to $ 147.51K, with a yearly change of -16.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $147.51K | +2900.00% |
| 2024 | $4.92K | -90.00% |
| 2023 | $49.17K | -72.97% |
| 2022 | $181.93K | +42.31% |
| 2021 | $127.84K | -71.11% |
| 2020 | $442.54K | -27.42% |
| 2019 | $609.72K | -49.39% |
| 2018 | $1.20 Million | -38.75% |
| 2017 | $1.97 Million | +2.56% |
| 2016 | $1.92 Million | +160.00% |
| 2015 | $737.57K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Entest Biomedical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.51K USD |
| MoneyControl | $147.51K USD |
| MarketWatch | $147.51K USD |
| marketcap.company | $147.51K USD |
| Reuters | $147.51K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.